Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 13 , ISSUE 4 ( July-August, 2021 ) > List of Articles


A Study of Maternal and Perinatal Outcomes in Pregnancy with Heart Diseases: Validation of CARPREG II Risk Prediction Index

Deepika Gurnani, Preeti F Lewis, Sana T Bijapur

Keywords : CARPREG II risk prediction index, Heart disease, Maternal outcome, Perinatal outcome, Pregnancy

Citation Information : Gurnani D, Lewis PF, Bijapur ST. A Study of Maternal and Perinatal Outcomes in Pregnancy with Heart Diseases: Validation of CARPREG II Risk Prediction Index. J South Asian Feder Obs Gynae 2021; 13 (4):254-258.

DOI: 10.5005/jp-journals-10006-1941

License: CC BY-NC 4.0

Published Online: 20-11-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Aim and objective: The aim of the study was to assess efficacy of CARPREG II risk prediction index in predicting poor maternal outcomes in pregnancies with heart diseases. Materials and methods: This study was conducted in the department of obstetrics and gynecology at a tertiary care center in Mumbai. This was a retrospective study of 66 pregnant women with structural heart diseases. CARPREG II score was calculated for each patient as per history, clinical examination, specific lesion through echo findings, and delivery of antenatal care. Primary and secondary adverse cardiac outcomes were noted during antepartum and postpartum periods. Obstetric and perinatal outcomes were also recorded. Results: Mean age of the study population was 27.36 years. A total of 51.5% (n = 34) patients were primigravidae. Majority of the subjects about 59.09% (n = 39) had rheumatic heart diseases (RHDs) and 25.75% (n = 17) had congenital heart diseases (CHDs). Overall, vaginal delivery was the most common route with an increased rate of Cesarean section (41.07%) and instrumental vaginal delivery (16.6%). There was no significant difference in observed and expected values of primary maternal outcome (p value = 0.9). All the maternal adverse clinical events were more common in groups of patients with CARPREG II index of 4 or more, but in score <3, the risk index overestimated maternal adverse cardiac events. Perinatal complications did not show any correlation with CARPREG II score. Conclusion: Pregnancy with cardiac disease is associated with high maternal and fetal morbidity and mortality. CAREPREG II risk prediction index predicts maternal outcomes effectively and can be used routinely in clinical practices to assess the maternal risks. Clinical significance: Integration of general cardiac factors and disease-specific factors along with delivery of care predictor emphasizes the role of skilled antenatal care in improving outcomes in pregnancy with cardiac diseases.

PDF Share
  1. Bhatla N, Lal S, Behera G, et al. Cardiac disease in pregnancy. Int J Gynaecol Obstet 2003;82(2):153–159. DOI: 10.1016/s0020-7292(03)00159-0.
  2. Agrawal S, Agrawal A, Bhandari M, et al. Critical analysis of all pregnancies with heart disease, misses and near misses over 1-year period along with expert group so as to optimize outcome and improve patient care – need-based analysis. Heart India 2019;7(2):55–62. DOI: 10.4103/heartindia.heartindia_15_19.
  3. Selvarani G, Sivakumar GS, Swaminathan N, et al. Prevalence study on heart diseases among antenatal mothers. Int J Sci Stud 2017;5(5): 204–208. DOI: 10.17354/ijss/2017/423.
  4. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104(5):515–521. DOI: 10.1161/hc3001.093437.
  5. Silversides CK, Grewal J, Mason J, et al. Pregnancy outcomes in women with heart disease: the CARPREG II study. J Am Coll Cardiol 2018;71(21):2419–2430. DOI: 10.1016/j.jacc.2018.02.076.
  6. Drenthen W, Boersma E, Balci A, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010;31(17):2124–2132. DOI: 10.1093/eurheartj/ehq200.
  7. Owens A, Yang J, Nie L, et al. Neonatal and maternal outcomes in pregnant women with cardiac disease. J Am Heart Assoc 2018;7(21):e009395. DOI: 10.1161/JAHA.118.009395.
  8. Subbaiah M, Sharma V, Kumar S, et al. Heart disease in pregnancy: cardiac and obstetric outcomes. Arch Gynecol Obstet 2013;288(1): 23–27. DOI: 10.1007/s00404-013-2730-2.
  9. Salam S, Mushtaq S, Mohi-ud-Din K, et al. Maternal and fetal outcome in pregnancy with heart disease in tertiary care hospital in India. Int J Reprod Contracept Obstet Gynecol 2017;6(9):3947–3951. DOI: 10.18203/2320-1770.ijrcog20174041.
  10. Lumsden R, Barasa F, Park LP, et al. High burden of cardiac disease in pregnancy at a national referral hospital in Western Kenya. Glob Heart 2020;15(1):10. DOI: 10.5334/gh.404.
  11. Martins LC, Freire CM, Capuruçu CA, et al. Risk prediction of cardiovascular complications in pregnant women with heart disease. Arq Bras Cardiol 2016;106(4):289–296. DOI: 10.5935/abc.20160028.
  12. Joshi G, Joshi SC, Jha SK, et al. Maternal heart disease and pregnancy outcome: findings from a retrospective cohort in a tertiary care government hospital in Haldwani, Nainital. Nig J Cardiol 2015;12(2):120–123. DOI: 10.4103/0189-7969.152027.
  13. Beaton A, Okello E, Scheel A, et al. Impact of heart disease on maternal, fetal and neonatal outcomes in a low-resource setting. Heart 2019;105(10):755–760. DOI: 10.1136/heartjnl-2018-313810.
  14. Konar H, Chaudhuri S. Pregnancy complicated by maternal heart disease: a review of 281 women. J Obstet Gynaecol India 2012;62(3):301–306. DOI: 10.1007/s13224-012-0220-2.
  15. Nguyen Manh T, Bui Van N, Le Thi H, et al. Pregnancy with heart disease: maternal outcomes and risk factors for fetal growth restriction. Int J Environ Res Public Health 2019;16(12):2075. DOI: 10.3390/ijerph16122075.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.